nach oben

Clinical Rheumatology

Erschienen in:

01.03.2007 | Original Article

Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis

verfasst von: Mustafa Cesur, Zeynep Ozbalkan, Mehtap Akcil Temel, Yaşar Karaarslan

Erschienen in: Clinical Rheumatology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

There are so many studies that suggest the changes in lipid profiles and lipoprotein (a) [Lp(a)] are associated with early atherosclerosis in rheumatoid arthritis (RA). But there are some opposite studies also. Because of marked ethnicity differences in the distribution of Lp(a), we aimed to investigate the associations of Lp(a) levels and lipid changes in Turkish RA patients. There were 30 women and 20 men, a total of 50 patients with RA (mean age 47.6±13.2 years), included and 21 healthy women and 14 healthy men (mean age 45.7±14.5 years) were recruited as a control (C) group. Serum Lp(a), total cholesterol (TC), triglyceride (TG), HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) levels were analysed for each group. Analysis of six different studies was performed. In the RA and C groups, mean serum Lp(a) levels were 39.7±64.4 and 10.5±13.4 mg/dl, respectively (P=0.001). Mean TC levels were 189.2±142.5 and 174.0±29.3 mg/dl (P=0.294), mean TG levels were 121.4±65.4 and 106.5±80.0 mg/dl (P=0.030), mean HDL-C levels were 44.5±10.0 and 47.7±4.8 mg/dl (P=0.014) and mean LDL-C levels were 94.3±35.3 and 102.0±24.6 mg/dl (P=0.98), respectively. Analysis of the six studies showed Lp(a) level was higher and HDL level was lower in RA patients than in healthy controls. Patients with RA may have altered lipid profiles from one country to another one. Especially in Turkey, higher serum Lp(a), lower HDL-C and higher TG levels may be found in RA patients instead of some findings of other countries showing different results. Ethnicity may be a reason for these findings.

Cisternas M, Gutierrez MA, Klaassen J, Acosta AM, Jacobelli S (2002) Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol 29:1619–1622PubMed

Dursunoglu D, Evrengul H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, Kilic M (2005) Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 25:241–245PubMedCrossRef

Yoo WH (2004) Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 31:1746–1753PubMed

Park YB, Choi HK, Kim MY, Lee WK, Song J, Kim DK, Lee SK (2002) Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 113:188–193PubMedCrossRef

Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, Song CH, Lee J (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701–1704PubMed

Wallberg-Jonsson S, Ohman M, Rantapaa-Dahlqvist S (2004) Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? Scand J Rheumatol 33:373–379PubMedCrossRef

Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50:3444–3449PubMedCrossRef

Orem A, Deger O, Kulan K, Onder E, Kiran E, Uzunosmanoglu D (1995) Evaluation of lipoprotein (a) [Lp(a)] as a risk factor for coronary artery disease in the Turkish population. Clin Biochem 28:171–173PubMedCrossRef

Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP (1996) Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 276:544–548PubMedCrossRef

10.

Jones SM, Harris CP, Lloyd J, Stirling CA, Reckless JP, McHugh NJ (2000) Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann Rheum Dis 59:904–909PubMedCrossRef

11.

Dahlen GH, Slunga L, Lindblom B (1994) Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes. Clin Genet 46:46–51PubMed

12.

Kamboh MI, McGarvey ST, Aston CE, Ferrell RE, Bausserman L (2000) Plasma lipoprotein(a) distribution and its correlates among Samoans. Hum Biol 72:321–336PubMed

13.

Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS (1991) Racial (black–white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 84:160–167PubMed

14.

Bauman WA, Adkins RH, Spungen AM, Maloney P, Gambino R, Waters RL (1998) Ethnicity effect on the serum lipid profile in persons with spinal cord injury. Arch Phys Med Rehabil 79:176–180PubMedCrossRef

15.

Cobbaert C, Mulder P, Lindemans J, Kesteloot H (1997) Serum LP(a) levels in African aboriginal Pygmies and Bantus, compared with Caucasian and Asian population samples. J Clin Epidemiol 50:1045–1053PubMedCrossRef

16.

Koukkou E, Watts GF, Mazurkiewicz J, Lowy C (1994) Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin. J Clin Pathol 47:1105–1117PubMed

17.

Aono H, Ito M, Ozawa H, Waki T, Magari Y, Bello MC, Rodoriguez AG (1999) Lipoprotein(a) concentrations in healthy subjects in the Dominican Republic. Comparison with Japanese. Jpn Heart J 40:65–70PubMedCrossRef

18.

Cho HK, Shin G, Ryu SK, Jang Y, Day SP, Stewart G, Packard CJ, Shepherd J, Caslake MJ (2002) Regulation of small dense LDL concentration in Korean and Scottish men and women. Atherosclerosis 164:187–193PubMedCrossRef

19.

Hergenc G, Schulte H, Assmann G, von Eckardstein A (1999) Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis 145:147–156PubMedCrossRef

20.

Herd SL, Gower BA, Dashti N, Goran MI (2001) Body fat, fat distribution and serum lipids, lipoproteins and apolipoproteins in African-American and Caucasian-American prepubertal children. Int J Obes Relat Metab Disord 25:198–204PubMedCrossRef

21.

Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, Francis CK, Marx HF, Philbin EF, Reed RG, Berglund L (2000) High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and White men. Arterioscler Thromb Vasc Biol 20:2619–2624PubMed

22.

Wung SF, Aouizerat BE (2003) Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics. Res Theory Nurs Pract 7:281–299 (discussion 335–338)CrossRef

23.

Ranjith N, Pegoraro RJ, Rom L, Rajput MC, Naidoo DP (2004) Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction. Cardiovasc J S Afr 15:111–117PubMed

24.

Tan JH, Low PS, Tan YS, Tong MC, Saha N, Yang H, Heng CK (2003) ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet 113:106–117PubMed

25.

Barbagallo CM, Polizzi F, Severino M, Rizzo M, Vivona N, Onorato F, Caldarella R, Cefalu AB, Noto D, Notarbartolo A, Averna MR (2001) ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size. Eur J Epidemiol 17:707–713PubMedCrossRef

26.

Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G (1992) Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb 12:1214–1226PubMed

27.

Kim JQ, Song JH (1994) High allele frequency of apolipoprotein(a) phenotype LpS4 is associated with low serum Lp(a) concentrations in Koreans. Clin Biochem 27:57–62PubMedCrossRef

28.

Serdar A, Yesilbursa D, Serdar Z (2001) Lipoprotein (a) as a risk factor for coronary artery disease in women and elderly patients. Anadolu Kardiyol Derg 1:259–263 (AXV-XVI, article in Turkish)PubMed

29.

Orem A, Deger O, Onder E, Karahan SC, Efe H, Uzunosmanoglu D (1994) Distribution of serum lipoprotein (a) concentrations in a healthy Turkish population. Ann Clin Biochem 31:343–346PubMed

30.

Mahley RW, Pepin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP (2000) Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. J Lipid Res 41:1290–1301PubMed

31.

Isbir T, Yilmaz H, Agachan B, Karaali ZE (2003) Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population. Clin Genet 64:228–234PubMedCrossRef

32.

Gocmen YA, Semiz E, Gumuslu S (2005) Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region. Eur J Cardiovasc Prev Rehabil 12:185–186PubMedCrossRef

33.

Koycu B, Kara T, Camlidag O, Aydinli R, Verschuren WM, van Montfrans GA (1997) Risk factors for cardiovascular diseases in Turks in Amsterdam and in Ankara. Ned Tijdschr Geneeskd 141:882–888 (article in Dutch)PubMed

34.

Mahley RW, Arslan P, Pekcan G, Pepin GM, Agacdiken A, Karaagoglu N, Rakicioglu N, Nursal B, Dayanikli P, Palaoglu KE, Bersot TP (2001) Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. J Lipid Res 42:1996–2006PubMed

35.

Molokhia M, McKeigue P (2000) Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res 2:115–125PubMedCrossRef

36.

Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA (2004) Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 50:400–412PubMedCrossRef

37.

Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Fischbach M, Escalante A (2003) Ethnic variation in the clinical manifestations of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum 49:200–208PubMedCrossRef

38.

Balsa A, Minaur NJ, Pascual-Salcedo D, McCabe C, Balas A, Fiddament B, Vicario JL, Cox NL, Martin-Mola E, Hall ND (2000) Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain). Rheumatology (Oxford) 39:844–849CrossRef

39.

Kong KF, Yeap SS, Chow SK, Phipps ME (2002) HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 35:235–239PubMedCrossRef

40.

Balsa A, Barrera P, Westhovens R, Alves H, Maenaut K, Pascual-Salcedo D, Cornelis F, Bardin T, Riente L, Radstake TR, de Almeida G, Lepage V, Stravopoulos C, Spaepen M, Lopes-Vaz A, Charron D, Martinez M, Prudhomme JF, Migliorini P, Fritz P (2001) European Consortium on Rheumatoid Arthritis Families (ECRAF). Clinical and immunogenetic characteristics of European multicase rheumatoid arthritis families. Ann Rheum Dis 60:573–576PubMedCrossRef

41.

Wordsworth BP, Salmon M (1992) The HLA class II component of susceptibility to rheumatoid arthritis. Baillieres Clin Rheumatol 6:325–336PubMedCrossRef

42.

Yazici H, Schreuder I, Yurdakul S, Ozbakir F (1987) HLA-B27 in Turkish patients with rheumatoid arthritis (letter). Ann Rheum Dis 46:718PubMed

43.

Saruhan-Direskeneli G (1998) Shared epitope homozygosity is strongly associated with rheumatoid arthritis in Turkey. Istanbul Rheumatology Study Group. Br J Rheumatol 37:1126–1128PubMedCrossRef

44.

Gonzalez A, Nicovani S, Massardo L, Bull P, Rodriguez L, Jacobelli S (1992) Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum 35:282–289PubMed

45.

Sanchez B, Moreno I, Magarino R, Garzon M, Gonzalez MF, Garcia A, Nunez-Roldan A (1990) HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 36:174–176PubMed

46.

de Vries N, Ronningen KS, Tilanus MG, Bouwens-Rombouts A, Segal R, Egeland T, Thorsby E, van de Putte LB, Brautbar C (1993) HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41:26–30PubMed

47.

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed

48.

Lwanga SK, Lemeshow S (1991) Sample size determination in health studies—a practical manual, 1st edn. World Health Organization, Geneva, pp 1–3

49.

Seriolo B, Accardo S, Fasciolo D, Bertolini S, Cutolo M (1996) Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis. Clin Exp Rheumatol 14:593–599PubMed

50.

Asanuma Y, Kawai S, Aoshima H, Kaburaki J, Mizushima Y (1999) Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum 42:443–447PubMedCrossRef

51.

Akcil M, Karaagaoglu E (1999) Meta-analysis of life constructs in antihypertensive drug theraphies. Tr J Med Sci 29:455–460

52.

Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N (2003) The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348:1170–1175PubMedCrossRef

53.

Pearce N, Foliaki S, Sporle A, Cunningham C (2004) Genetics, race, ethnicity, and health. BMJ 328:1070–1072PubMedCrossRef

54.

Jorgenson E, Tang H, Gadde M, Province M, Leppert M, Kardia S, Schork N, Cooper R, Rao DC, Boerwinkle E, Risch N (2005) Ethnicity and human genetic linkage maps. Am J Hum Genet 76:276–290PubMedCrossRef

55.

Lee YH, Choi SJ, Ji JD, Seo HS, Song GG (2000) Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 19:324–325PubMedCrossRef

56.

Busso N, Dudler J, Salvi R, Peclat V, Lenain V, Marcovina S, Darioli R, Nicod P, So AK, Mooser V (2001) Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints. Am J Pathol 159:1445–1453PubMed

57.

Borba EF, Santos RD, Bonfa E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhao RC (1994) Lipoprotein(a) levels in systemic lupus erythematosus. J Rheumatol 21:220–223PubMed

58.

Rohlen T, Sasaki Y, Wagatsuma H, Wetherall WO (1981) Koreans in Japan. In: Lee C, De Vos G (eds) Ethnic conflict and accommodation, chapter 12. University of California Press, Berkeley, pp 281–303 (text), 406–413 (notes)

59.

Rainwater DL, Kammerer CM, Vande Berg JL (1999) Evidence that multiple genes influence baseline concentrations and diet response of Lp(a) in baboons. Arterioscler Thromb Vasc Biol 19:2696–2700PubMed

60.

Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS (1989) HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15–21PubMed

61.

Maeda H, Juji T, Mitsui H, Sonozaki H, Okitsu K (1981) HLA DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis 40:299–302PubMed

62.

Hong GH, Park MH, Takeuchi F, Oh MD, Song YW, Nabeta H, Nakano K, Ito K, Park KS (1996) Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value. J Rheumatol 23:1699–1703PubMed

63.

Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004) A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50:3085–3092PubMedCrossRef

64.

Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, Bruce B (2002) HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum 46:2320–2329PubMedCrossRef

65.

Teller K, Budhai L, Zhang M, Haramati N, Keiser HD, Davidson A (1996) HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the “shared epitope” hypothesis may not apply. J Rheumatol 23:1363–1368PubMed

66.

Massardo L, Gareca N, Cartes MA, Cervilla V, Gonzalez A, Jacobelli S (2002) The presence of the HLA-DRB1 shared epitope correlates with erosive disease in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford) 41:153–156CrossRef

67.

Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, Mikhail IS, Trentham DE, Leisen JC, Bluhm G, Cooper SM, Duncan H, Tuttleman M, Heyse SP, Sharp JT, Tilley B (1996) HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in rheumatoid arthritis. Arthritis Rheum 39:1802–1807PubMed

68.

McDaniel DO, Alarcon GS, Pratt PW, Reveille JD (1995) Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope). Ann Intern Med 23:181–187

69.

Jonasson L, Eriksson T, Dahle’n GH, Lindblom B (1997) Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease. Atherosclerosis 133:111–1114PubMedCrossRef

70.

Giger JN, Strickland OL, Weaver M, Taylor H, Acton RT (2005) Genetic predictors of coronary heart disease risk factors in premenopausal African-American women. Ethn Dis 15:221–232PubMed

71.

Akdemir R, Ozhan H, Gunduz H, Erbilen E, Yazici M, Duran S, Orkunoglu F, Albayrak S, Imirzalioglu N, Uyan C (2004) HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia. Acta Cardiol 59:499–502PubMedCrossRef

Titel: Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis
verfasst von: Mustafa Cesur
Zeynep Ozbalkan
Mehtap Akcil Temel
Yaşar Karaarslan
Publikationsdatum: 01.03.2007
Verlag: Springer-Verlag
Erschienen in: Clinical Rheumatology / Ausgabe 3/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-006-0303-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Krebspatienten impfen: Was? Wen? Und wann nicht?

Nierenultraschall: Tipps vom Profi

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2007

Paraoxonase and arylesterase levels in rheumatoid arthritis

Age as a predicting factor in the therapy outcome of multidisciplinary treatment of patients with chronic low back pain—a prospective longitudinal clinical study in 405 patients

Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still’s disease

Val/Leu247 and Trp/Ser316 polymorphisms in β2 glycoprotein I and their association with thrombosis in unselected Chilean patients

Oxidant/antioxidant status in men with Behçet’s disease

From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Krebspatienten impfen: Was? Wen? Und wann nicht?

Nierenultraschall: Tipps vom Profi

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

„KI sieht, was wir nicht sehen“

Update Innere Medizin